Alzheimer's drug fails to reduce significant agitation
Wednesday, May 2, 2012 - 20:30
in Health & Medicine
A drug prescribed for Alzheimer's disease does not ease clinically significant agitation in patients, according to first randomized controlled trial designed to assess the effectiveness of the drug (generic name memantine) for significant agitation in Alzheimer's patients.
Read the whole article on Science Daily
More from Science Daily
Related
- Study explains why Alzheimer's drug is both safe and effectiveWed, 18 Aug 2010, 14:30:25 EDT
- Humor as effective as medication in treating agitation in dementia Wed, 21 Sep 2011, 21:33:24 EDT
- Alzheimer's disease patients show improvement in trial of new drugTue, 29 Jul 2008, 15:22:09 EDT
- Delirium rapidly accelerates memory decline in Alzheimer's patientsMon, 4 May 2009, 16:52:51 EDT
- Epilepsy drug may help Alzheimer's patientsMon, 27 Oct 2008, 10:36:24 EDT